Secure and Adaptable Ultrasound-Enhanced Ophthalmic Drug Delivery Systems for Niche Environments

Publication ID: 24-11857459_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Secure and Adaptable Ultrasound-Enhanced Ophthalmic Drug Delivery Systems for Niche Environments,” Published Technical Disclosure No. 24-11857459_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857459_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,459.

Summary of the Inventive Concept

This inventive concept adapts the original ultrasound-enhanced ophthalmic drug delivery system for specialized markets, focusing on high-security, extreme weather, disaster relief, extreme temperatures, and high-altitude environments. It integrates advanced encryption, weather-resistant designs, compact battery-powered devices, temperature-controlled components, and altitude-compensating software to address the unique challenges of these niche markets.

Background and Problem Solved

The original ultrasound-enhanced ophthalmic drug delivery system has limitations in adapting to specific, high-stakes environments. This inventive concept addresses these limitations by providing tailored solutions for secure, reliable, and efficient drug delivery in situations where conventional systems may fail or be compromised.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of specialized systems and methods for ultrasound-enhanced ophthalmic drug delivery. For high-security environments, the system incorporates advanced encryption and secure data transmission protocols in the ultrasound-generating device, ensuring the integrity of sensitive information. For extreme weather conditions, the system features a portable, weather-resistant ultrasound-generating device and a drug applicator with a weather-sealed design. In disaster relief situations, the system comprises a compact, battery-powered ultrasound-generating device and a drug applicator designed for rapid, single-use application. For extreme temperatures, the system includes an ultrasound-generating device with temperature-controlled components and a drug applicator with thermal insulation. Finally, for high-altitude environments, the system features an ultrasound-generating device with altitude-compensating software and a drug applicator designed for low-pressure operation. These adaptations enable the system to maintain its efficacy and reliability in challenging environments.

Novelty and Inventive Step

The inventive concept's novelty lies in its ability to adapt the original ultrasound-enhanced ophthalmic drug delivery system to specific, high-stakes environments. The inventive step is the integration of advanced encryption, weather-resistant designs, compact battery-powered devices, temperature-controlled components, and altitude-compensating software, which provides a new level of security, reliability, and efficiency in these niche markets.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different encryption protocols, varying weather-resistant materials, or alternative power sources for the ultrasound-generating device. Variations could also involve adapting the system for use in other specialized environments, such as space exploration or military operations.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the ophthalmic pharmaceutical industry, particularly in the areas of high-security facilities, disaster relief, and extreme environment operations. The market for these specialized systems is expected to grow as the need for secure and reliable drug delivery solutions increases in these niche environments.

CPC Classifications

SectionClassGroup
A A61 A61F9/0008
A A61 A61M37/0092
A A61 A61F2250/0093

Original Patent Information

Patent NumberUS 11,857,459
TitleSystem and method for ultrasound-enhanced delivery of drugs
Assignee(s)SONIKURE HOLDINGS LIMITED